Quantum Innovations sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-01-31
Share capital
14,200.00 PLN
Activity description

Quantum Innovations creates technologies for cardiac surgery, cardiology and respiratory medicine. Its products include the Heart Sense probe, designed to increase safety during cardiac surgery, and Heart Guard, a system for continuous measurement of cardiac metabolism; the devices aim to improve the safety of invasive procedures in cardiac surgery centers.

Registered address
Plac Bankowy 2, 00-095 Warszawa, Poland
Electronic delivery address
AE:PL-44739-91928-BVFCT-25

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 32 days late). 2 of 6 audited by a statutory auditor.

  • 202524/06/2026
  • 202426/06/2025
  • 202318/04/2024
  • 202209/06/2023
  • 202116/08/2022
  • 202016/07/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Top 37%
City · Warszawa31,575 / 56,955
Top 55%
Voivodeship · Mazowieckie43,966 / 77,195
Top 57%
Country · Poland173,849 / 298,026
Top 58%

Results vs industry

Revenue
This companyUSD 167.49kMedianUSD 56.72kAverageUSD 2.72m
Net profit
This companyUSD -447.76kMedianUSD -1.27kAverageUSD -92.87k
Operating costs
This companyUSD 613.45kMedianUSD 66.48kAverageUSD 2.68m
Assets
This companyUSD 4.41mMedianUSD 134.71kAverageUSD 3.04m

Offer

  • Research on cardiac technologies
  • Cardiac surgery probe
  • Cardiac metabolism measurement system

Websites

Trademarks

The company holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 2024.

MarkNumberClassesStatusProtected until
QUANTUM INNOVATIONS (word)Z.5770319, 10, 41, 42, 44Protected Nov 20, 2034
MarkProtected until
QUANTUM INNOVATIONS (word)Nov 20, 2034

Authorized Representatives

Przemysław Robert Furdal age 38 – Vice President of the Management Board
Grzegorz Łukasz Suwalski age 47 – President of the Management Board
Pawlos Theodoros Mandzios age 39 – Vice President of the Management Board

Manner of representation

Declarations of will on behalf of the company require the joint action of two members of the management board or one member of the management board and a commercial proxy. If a member of the management board representing the investor is appointed, declarations of will on behalf of the company require the joint action of the member of the management board–the Finance Director–with another member of the management board or a commercial proxy.

Supervisory board

Andrzej Michał Morawiec age 67 – Supervisory Board Member
Elżbieta Janina Malinowska age 74 – Supervisory Board Member
Monika Prokopowicz age 40 – Supervisory Board Member

Ownership

OwnerSharesShare valueStake
64$864.4022.5352%
64$864.4022.5352%
78$1,053.4827.4648%
78$1,053.4827.4648%

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2017-08-10.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$8,008
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,883
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$5,787

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Orthoget S.A.
Aidmed sp. z o.o.
F.R.K. Intra-Cordis sp. z o.o.
AUG Medical sp. z o.o.
Accrea Engineering sp. z o.o.
Hagmed sp. z o.o.
Spark Group sp. z o.o.
Medinice B+R sp. z o.o.
OPTI G sp. z o.o.
Simplicardiac S.A.

Change history

DateEvent
2025-11-13Address change
2024-10-01Share capital increase
2024-08-21Address change
2024-06-25Share capital increase
2021-06-25Address change

FAQ

Last updated: 2026-06-24